Molecular templates, inc. (MTEM)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets:
Cash and cash equivalents

34,444

85,451

15,268

16,795

37,855

87,721

78,744

41,647

49,275

58,910

68,181

16,468

11,438

1,716

15,155

12,402

11,211

9,589

13,709

10,569

21,063

8,391

11,240

6,463

6,743

7,279

4,001

4,413

20,355

11,029

8,634

8,307

25,935

5,882

6,076

10,597

8,691

Marketable securities, current

70,544

39,633

36,147

55,529

45,720

10,234

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

3,727

2,318

2,340

2,258

2,005

2,244

2,535

1,653

1,477

1,485

-

-

-

120

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Grants revenue receivable

9,441

7,100

5,591

5,160

-

4,329

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable, related party

1,300

408

0

0

295

240

31,163

663

4,000

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

In-process research and development - held for sale

4,500

4,500

4,500

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current assets

242

489

300

98

5,085

95

4,385

191

144

19

-

-

-

7

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

-

-

-

-

-

-

-

-

-

-

38

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities, current

-

-

-

-

-

-

-

-

-

-

-

300

6,163

-

12,955

21,189

26,755

39,091

42,705

56,450

57,822

50,209

-

-

-

58,390

-

-

-

-

-

-

-

-

-

-

-

Collaboration receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

400

921

777

1,891

4,032

3,647

-

7,248

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Notes receivable

-

-

-

-

-

-

-

-

-

-

-

4,000

2,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities, current

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

56,505

56,571

65,250

-

87,913

93,799

83,883

59,819

57,191

58,228

23,796

14,408

19,211

20,897

6,008

Collaboration receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,993

-

4,463

4,263

5,192

18,094

5,545

2,548

6,653

15,635

17,457

16,412

37,540

0

-

-

-

Prepaid expenses and other current assets

-

-

-

-

-

-

-

-

-

-

1,363

93

352

-

1,022

1,294

1,880

2,599

1,785

1,500

1,226

832

1,888

2,845

1,311

2,246

1,819

1,913

1,162

1,167

1,149

1,652

767

254

830

1,080

473

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

471

Total current assets

124,198

139,899

64,146

79,840

90,960

104,863

116,827

44,154

54,896

60,414

69,582

20,861

19,953

1,843

29,532

35,806

40,623

53,170

62,231

72,166

82,104

66,680

74,096

70,142

78,496

86,009

99,278

102,673

112,053

87,650

84,431

84,599

88,038

20,544

26,117

32,574

15,643

Marketable securities, non-current

3,010

1,510

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease right-of-use assets, non-current

9,617

9,959

10,397

10,796

11,131

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities, non-current

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,201

-

778

12,181

14,393

16,364

-

-

-

-

-

-

-

-

-

-

-

Property and equipment, net

19,301

18,158

13,884

9,151

7,108

6,851

7,165

7,237

4,294

1,952

963

0

0

334

159

208

261

333

404

424

503

557

637

690

632

686

708

773

760

812

728

684

617

543

409

128

271

In-process research and development

-

-

-

26,623

26,623

26,623

26,623

26,623

26,623

26,623

27,300

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

-

-

-

-

-

-

-

-

-

-

3,314

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets

-

-

-

-

-

-

-

-

-

-

1,321

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

4,617

4,676

4,735

4,737

4,783

1,821

1,345

1,402

1,402

1,402

57

-

-

921

0

166

166

166

1,329

1,264

1,201

1,159

1,159

1,159

1,159

1,059

1,059

1,059

1,059

1,059

1,059

1,059

1,059

1,349

349

290

290

Total assets

160,743

174,202

93,162

131,147

140,605

140,158

151,960

79,416

87,215

90,391

102,537

20,861

19,953

3,098

29,691

36,180

41,050

53,669

63,964

73,854

88,009

68,396

76,670

84,172

94,680

104,118

101,045

104,505

113,872

89,521

86,218

86,342

89,714

22,436

26,875

32,992

16,204

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable

1,770

1,465

1,414

2,577

1,582

780

1,630

1,283

2,859

2,517

3,823

319

328

934

699

3,076

1,563

725

436

635

1,809

2,074

3,414

2,891

4,006

1,689

1,375

884

2,354

908

739

995

1,307

2,389

305

478

252

Collaboration payable

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued clinical and development expenses

-

-

-

-

-

-

-

-

-

-

-

246

178

-

1,908

2,097

3,325

6,834

5,898

7,720

8,248

5,998

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued clinical and development expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,444

-

-

-

-

-

-

-

-

-

-

-

Accrued clinical and development expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,142

7,173

5,492

-

8,291

7,019

5,624

5,750

6,445

3,801

4,703

4,465

-

-

-

Accrued clinical and development expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,461

2,677

2,439

Accrued liabilities

11,531

14,544

9,105

7,120

5,979

5,357

6,595

6,231

2,800

2,690

1,500

1,915

1,704

1,210

1,112

616

687

3,269

3,202

2,451

4,196

3,180

2,697

2,511

3,962

3,161

2,489

2,041

3,090

2,257

1,817

1,437

2,016

1,737

1,621

1,315

823

Deferred revenue, current

-

-

11,956

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of long-term debt

-

-

-

-

-

-

0

0

0

2,400

2,348

-

-

2,400

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of capital lease obligations

-

-

-

-

-

-

-

-

-

-

51

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Related party debt (Note 8)

-

-

-

-

-

-

-

-

-

-

0

-

-

7,315

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, current

11,465

8,511

-

14,561

19,307

26,231

33,400

5,658

6,350

2,765

3,585

-

-

1,870

-

-

-

-

14,722

14,722

14,722

14,722

14,722

14,722

14,722

14,722

12,722

12,722

12,722

8,536

7,188

7,188

7,188

0

-

-

-

Deferred revenue, current, related party

8,773

8,780

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current liabilities, related party

7,754

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current liabilities

2,543

2,501

1,623

1,435

1,232

141

106

104

98

70

-

-

-

36

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

43,836

35,801

24,098

25,693

28,100

32,509

41,731

13,276

12,107

10,442

11,307

2,480

2,210

13,765

3,719

5,789

5,575

10,828

24,258

25,528

28,975

25,974

24,975

27,297

28,182

27,016

24,877

22,666

23,790

17,451

16,189

13,421

15,214

8,591

5,387

4,470

3,514

Deferred revenue, non-current

-

-

1,236

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital lease obligations, net of current portion

-

-

-

-

-

-

-

-

-

-

60

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liabilities

-

-

-

-

-

-

38

42

340

954

1,392

1,494

2,407

49

2,988

2,490

1,494

1,864

19,295

19,627

20,185

3,961

-

-

-

23,421

-

-

-

-

-

-

-

-

-

-

-

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,564

15,299

21,964

-

23,790

33,983

35,646

32,558

67,373

75,759

101,625

9,209

12,030

15,689

7,499

Deferred revenue, long-term

14,523

18,944

-

1,664

2,065

2,670

-

-

-

0

-

-

-

-

-

-

-

-

51,153

54,833

58,513

62,194

65,874

69,555

73,235

76,916

69,628

72,809

75,989

53,097

46,467

48,263

50,060

0

-

-

-

Deferred revenue, long-term, related party

1,355

441

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

145

0

9

-

63

87

109

131

153

169

225

243

260

274

287

240

250

257

262

268

273

273

262

153

4

96

248

Long-term debt, net

2,888

2,940

3,001

3,075

3,159

3,254

3,155

3,063

2,999

1,078

1,734

-

-

3,165

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities, non-current

11,232

11,682

10,573

10,707

10,770

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

3,143

1,366

1,238

748

374

819

844

859

828

628

-

-

-

53

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

76,977

71,174

40,146

41,887

44,468

39,252

45,768

17,240

16,274

13,102

14,638

3,974

4,626

17,032

6,770

8,366

7,178

12,823

94,859

100,157

107,898

92,372

97,673

112,425

123,668

127,593

118,545

129,715

135,687

103,374

130,302

137,716

167,161

17,953

17,421

20,255

11,261

Commitments and contingencies (Note 10)

0

0

-

-

-

0

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Redeemable convertible preferred stock

-

-

-

-

-

-

-

-

-

-

0

-

-

25,871

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stockholders’ equity
Preferred stock, $0.001 par value: Authorized: 2,000,000 shares at March 31, 2020 and December 31, 2019; issued and outstanding: 250 shares at March 31, 2020 and December 31, 2019

0

0

-

-

-

0

-

-

-

-

-

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.001 par value: Authorized: 150,000,000 shares; issued and outstanding: 45,703,934 shares at March 31, 2020 and 45,589,157 shares at December 31, 2019

46

46

37

37

37

37

36

27

27

27

27

72

72

0

72

72

72

71

71

71

71

63

62

59

59

59

59

58

56

56

56

55

54

49

49

49

34

Additional paid-in capital

269,581

267,089

201,203

199,223

196,972

195,573

194,226

144,975

144,044

141,733

145,428

374,278

373,864

568

372,699

371,893

371,091

370,236

368,190

366,366

364,471

349,236

346,229

331,224

329,727

328,116

326,492

320,024

310,600

309,343

307,497

299,244

290,159

256,563

256,267

255,418

231,383

Accumulated other comprehensive income

282

18

20

25

0

0

0

0

0

0

0

0

-1

0

2

5

1

-21

-3

-18

-15

-13

4

17

13

28

38

-27

6

11

14

-13

1

-1

-9

-2

1

Accumulated deficit

-186,143

-164,125

-148,244

-110,025

-100,872

-94,704

-88,070

-82,826

-73,130

-64,471

-57,556

-357,463

-358,608

-40,373

-349,852

-344,156

-337,292

-329,440

-399,153

-392,722

-384,416

-373,262

-367,298

-359,553

-358,787

-351,678

-344,089

-345,265

-332,477

-323,263

-351,651

-350,660

-367,661

-252,128

-246,853

-242,728

-226,475

Total stockholders’ equity

83,766

103,028

53,016

89,260

96,137

100,906

106,192

62,176

70,941

77,289

87,899

16,887

15,327

-39,805

22,921

27,814

33,872

40,846

-30,895

-26,303

-19,889

-23,976

-21,003

-28,253

-28,988

-23,475

-17,500

-25,210

-21,815

-13,853

-44,084

-51,374

-77,447

4,483

9,454

12,737

4,943

Total liabilities and stockholders’ equity

160,743

174,202

93,162

131,147

140,605

140,158

151,960

79,416

87,215

90,391

102,537

20,861

19,953

3,098

29,691

36,180

41,050

53,669

63,964

73,854

88,009

68,396

76,670

84,172

94,680

104,118

101,045

104,505

113,872

89,521

86,218

86,342

89,714

22,436

26,875

32,992

16,204